Press Release

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Cellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformScience Minister Lord Vallance opens Digital and Automation Testbeds that will improve advanced therapies manufacturingScience Minister Lord Vallance opens Digital and Automation Testbeds that will improve advanced therapies manufacturingCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and JapanCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and JapanINmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessINmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessNetwork established to identify opportunities for regulation to support innovation within advanced therapiesNetwork established to identify opportunities for regulation to support innovation within advanced therapies70% increase in Phase I advanced therapy clinical trials in the UK in 202470% increase in Phase I advanced therapy clinical trials in the UK in 2024Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturingCell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturingCell and gene therapy industry continues to expand manufacturing infrastructure in the UKCell and gene therapy industry continues to expand manufacturing infrastructure in the UKCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesHsin Loke joins the Cell and Gene Therapy Catapult as Non-Executive DirectorHsin Loke joins the Cell and Gene Therapy Catapult as Non-Executive DirectorNew London-based Advanced Therapy Treatment Centre established to improve clinical trial infrastructureNew London-based Advanced Therapy Treatment Centre established to improve clinical trial infrastructureCell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Cell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024